证券记录 · 已归档季度
RZLT
Rezolute, Inc. · Healthcare · Biotechnology
10被追踪持有人
0Δ持有人
26.66M持有股份
$118.90M报告持仓市值
+2新建仓位
−2清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +7.5% · 净新建仓位 0.0% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 64 | +3 | 50.24M | $261.09M | +9 | −6 |
| Q1 2026 | 63 | +7 | 53.20M | $162.23M | +14 | −7 |
| Q4 2025 | 56 | +1 | 61.70M | $145.62M | +3 | −2 |
| Q3 2025 | 14 | +1 | 31.48M | $295.95M | +2 | −1 |
| Q2 2025 | 10 | 0 | 26.66M | $118.90M | +2 | −2 |
| Q1 2025 | 7 | -1 | 3.87M | $11.23M | — | −1 |
| Q4 2024 | 8 | 0 | 4.74M | $23.24M | — | — |
| Q3 2024 | 7 | +1 | 2.88M | $13.99M | +1 | — |
| Q2 2024 | 6 | — | 2.25M | $9.69M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 12.81M | — | $57.14M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 12.81M | — | $57.14M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 4.08M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 4.08M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 4.08M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 4.08M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 4.08M | — | $18.20M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | The Vanguard Group ✦ (被动) | 4.02M | — | $17.94M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | The Vanguard Group ✦ (被动) | 4.02M | — | $17.94M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | The Vanguard Group ✦ (被动) | 4.02M | — | $17.94M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Marshall Wace ✦ | 2.89M | +56.4% | $12.87M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | Marshall Wace ✦ | 2.89M | +56.4% | $12.87M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Marshall Wace ✦ | 2.89M | +56.4% | $12.87M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Geode Capital Management ✦ (被动) | 1.71M | +201.7% | $7.63M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Geode Capital Management ✦ (被动) | 1.71M | +201.7% | $7.63M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | State Street Global Advisors ✦ (被动) | 830.07K | +319.9% | $3.70M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 211.51K | 新增 | $943,331 | 0.0% | New | 1 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 52.83K | -86.0% | $235,635 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 33.56K | 新增 | $150,000 | 0.0% | New | 1 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 16.60K | -84.8% | $74,040 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $943,331 | 0.0% |
| T. Rowe Price | $150,000 | 0.0% |
已清仓
| Millennium Management | $2.12M | 曾为 0.0% |
| Two Sigma Investments | $123,340 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 81.00K 股份, $247 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据